zollinger-ellison%20syndrome
ZOLLINGER-ELLISON SYNDROME
Zollinger-Ellison syndrome (ZES) is a disease entity which refers to the triad of severe peptic ulcer disease (PUD), gastric acid hypersecretion and non-beta cell gastrin-secreting tumor primarily of the pancreas and duodenum (gastrinoma).
Approximately two-thirds of patients have sporadic ZES while the rest is part of multiple endocrine neoplasia type 1.
ZES should be considered in the differential diagnoses of patients who present with abdominal pain, malabsorption and chronic watery diarrhea.
A high index of clinical awareness is necessary to correctly diagnose ZES.

Introduction

  • Zollinger-Ellison Syndrome (ZES) is a disease entity which refers to the triad of severe peptic ulcer disease (PUD), gastric acid hypersecretion & non-beta cell gastrin-secreting tumor primarily of the pancreas & duodenum (gastrinoma)
  • Approximately two-thirds of patients have sporadic ZES while the rest is part of multiple endocrine neoplasia type 1 (MEN-1)
    • Gastrinomas that occur in relation w/ MEN-1 are associated w/ a lower chance of metastases compared to gastrinomas in sporadic ZES

Epidemiology

  • Estimated incidence of ZES is 0.1-3 patients per million population
  • Most patients are diagnosed between the ages of 20 & 65, but as old as 90 & as young as 7 have been identified
    • Mean age of onset is 41 yr, w/ a slight male predominance
    • Mean delay in the diagnosis is 5-6 yr; the widespread use of PPIs contributes significantly to the delay in diagnosis

Signs and Symptoms

ZES should be considered in the differential diagnoses of patients who present w/ abdominal pain,malabsorption & chronic watery diarrhea

Abdominal Pain

  • Most common symptom, typically felt in the epigastric area & may mimic PUD
  • Pancreatitis, which may cause abdominal pain & malabsorption, may occur concomitantly w/ ZES

Diarrhea

  • Occurs secondary to malabsorption that results from large amounts of gastric acid that go into the small intestine, causing inactivation of pancreatic digestive enzymes & damage to the gut mucosa
  • Malabsorption leading to diarrhea (& sometimes steatorrhea) may also be caused by precipitation of bile salts
  • Diarrhea is seen less frequently in patients w/ MEN-1-associated ZES than in those w/ sporadic ZES
  • May occur together w/ abdominal pain in about half of patients w/ ZES

Heartburn

  • May mimic gastroesophageal reflux disease (GERD)

GI Bleeding

  • Often develops as a consequence of peptic ulceration

Other symptoms

  • Nausea & vomiting (N/V), wt loss

Other Clinical Features Suspicious of ZES

  • Multiple duodenal &/or jejunal ulcers; postbulbar duodenal ulcer
  • PUD that is poorly responsive to medical therapy
  • PUD associated w/ chronic diarrhea
  • PUD not associated w/ Helicobacter pylori or nonsteroidal anti-inflammatory drugs (NSAIDs) use
  • Family history of PUD & hypercalcemia
  • In patients in whom MEN-1-associated ZES is considered, symptoms &/or a family history of associated disorders ie hypercalcemia, nephrolithiasis, pituitary disorders & hyperparathyroidism should be elicited
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Christina Lau, 03 Oct 2017

A new technology involving the use of monocyte-derived hepatocyte-like (MH) cells has demonstrated high sensitivity and specificity in the diagnosis of idiosyncratic drug-induced liver injury (DILI), data presented at the Asian Pacific Digestive Week (APDW) 2017 held in Hong Kong have shown.